Back to NRIX

Vestal Point Capital, LP → NRIX

Vestal Point Capital, LP NRIX Position History

Nurix Therapeutics, Inc.

Quarters held
4
Latest value
$166.6M
Q3 2026
Peak value
$195.3M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$89M
Q1 2026$100.8M
Q2 2026$195.3M
Q3 2026$166.6M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$166.6M7.03M——
Q2 2026$195.3M8.05M——
Q1 2026$100.8M6.50M——
Q4 2025$89M4.69M——

Other funds holding NRIX

Other Vestal Point Capital, LP positions

AAVXF

Abivax SA

$392.1M
NBIX

Neurocrine Biosciences Inc

$354.6M
BMRN

BioMarin Pharmaceutical Inc

$344.8M
BMRN

BioMarin Pharmaceutical Inc

$331.5M
NBIX

Neurocrine Biosciences Inc

$316.8M
ARWR

Arrowhead Pharmaceuticals Inc

$315.1M
AAVXF

Abivax SA

$313.1M
INSM

Insmed Inc

$311M